Elotuzumab

ATC L01FX08 · 8 markets · 16 records

Elotuzumab 8 markets · 16 records Forms

AU 5 records · 5 strengths

400 mginjectionEMPLICITI also in US·GB·ES
300 mginjectionEMPLICITI also in US·GB
440 mginjectionEMPLICITI elotuzumab 300mg lyophilized powder for IV infusion vial unknown
340 mginjectionEMPLICITI elotuzumab 300mg lyophilized powder for IV infusion vial unknown

Records without a stated strength · 1 EMPLICITI

US 2 records · 2 strengths

400 mginjectionEMPLICITI also in AU·GB·ES
300 mginjectionEMPLICITI also in AU·GB

GB 2 records · 2 strengths

400 mginjectionEmpliciti 400mg powder for concentrate for solution for infusion vials also in AU·US·ES
300 mginjectionEmpliciti 400mg powder for concentrate for solution for infusion vials also in AU·US

HK 2 records · 1 strengths

Records without a stated strength · 1 EMPLICITI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG

ES 1 records · 1 strengths

400 mginjectionEMPLICITI also in AU·US·GB

TW 1 records · 1 strengths

Records without a stated strength · 1 Empliciti TM (elotuzumab) For Injection、恩必喜凍晶注射劑

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 EMPLICITI

Side-by-side table

Strength / form / release	US	GB	AU	ES	TW	HK	EU
400 mg injection	EMPLICITI	Empliciti 400mg powder for concentrate for solution for infusion vials	EMPLICITI	EMPLICITI	not recorded	not recorded	not recorded
300 mg injection	EMPLICITI	Empliciti 400mg powder for concentrate for solution for infusion vials	EMPLICITI	not recorded	not recorded	not recorded	not recorded
440 mg injection	not recorded	not recorded	EMPLICITI elotuzumab 300mg lyophilized powder for IV infusion vial	not recorded	not recorded	not recorded	not recorded
340 mg injection	not recorded	not recorded	EMPLICITI elotuzumab 300mg lyophilized powder for IV infusion vial	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	EMPLICITI	not recorded	not recorded	EMPLICITI POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG	EMPLICITI
not disclosed injection	not recorded	not recorded	not recorded	not recorded	Empliciti TM (elotuzumab) For 恩必喜凍晶注射劑	not recorded	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

1 more strength/form rows are recorded only in TW and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en TW que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 TW 有记录（未在本表显示）。另有 1 個規格/劑型僅在 TW 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.